Skip to toolbar

FDA approves first drug to treat inherited breast cancer

OurBot
CBSNEWS.COM -U.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene.The Food and Drug Administration on Friday approved AstraZeneca PLC’s Lynparza for patients with inherited BRCA gene mutations who have undergone chemotherapy.The drug has been on the market since 2014 for ovarian cancer, and is the first in a new class of medicines called PARP inhibitors to ..Read more»

Fact Check
Fact-Check
Quick Rate
Ratings
Ratings
This article does not have enough ratings yet to calculate a Score. Please consider fact-checking and rating this article!
NA
Score

← Previous Post
Next Post →

Welcome! Please Login, or Join for free to rate.